Therapeutic Compatibility of Orally Administered Racemic Ketamine with Modafinil, a CYP3A4 Enzyme Inducer, in Treatment-Refractory Major Depressive Disorder.

Journal: Indian journal of psychological medicine

Volume: 45

Issue: 6

Year of Publication: 

Affiliated Institutions:  Dept. of Clinical Psychopharmacology and Neurotoxicology, National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India.

Abstract summary 

Authors & Co-authors:  Andrade

Study Outcome 

Source Link: Visit source

Statistics
Citations :  Andrade C. Oral ketamine for depression: 2. Practical considerations. J Clin Psychiatry, 2019; 80: 19f12838.
Authors :  1
Identifiers
Doi : 10.1177/02537176231160264
SSN : 0253-7176
Study Population
Male,Female
Mesh Terms
Other Terms
Study Design
Study Approach
Country of Study
Publication Country
United States